A61K 9/1617
Organic compounds
Official title: {Organic compounds, e.g. phospholipids, fats}
A61K9/1617 (Organic compounds) appears on 2,829 US grants and 4,971 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,829
- Published applications
- 4,971
- Assignees
- 1,919
- Inventors
- 8,710
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 9 | 0 |
| 1987 | 5 | 0 |
| 1988 | 17 | 0 |
| 1989 | 32 | 0 |
| 1990 | 15 | 0 |
| 1991 | 14 | 0 |
| 1992 | 10 | 0 |
| 1993 | 15 | 0 |
| 1994 | 14 | 0 |
| 1995 | 26 | 0 |
| 1996 | 24 | 0 |
| 1997 | 35 | 0 |
| 1998 | 31 | 0 |
| 1999 | 50 | 0 |
| 2000 | 43 | 0 |
| 2001 | 62 | 30 |
| 2002 | 53 | 100 |
| 2003 | 70 | 169 |
| 2004 | 38 | 154 |
| 2005 | 45 | 152 |
| 2006 | 47 | 131 |
| 2007 | 35 | 179 |
| 2008 | 34 | 155 |
| 2009 | 34 | 150 |
| 2010 | 74 | 182 |
| 2011 | 66 | 161 |
| 2012 | 91 | 172 |
| 2013 | 119 | 164 |
| 2014 | 149 | 184 |
| 2015 | 120 | 224 |
| 2016 | 122 | 232 |
| 2017 | 154 | 266 |
| 2018 | 141 | 196 |
| 2019 | 140 | 224 |
| 2020 | 136 | 256 |
| 2021 | 135 | 268 |
| 2022 | 123 | 277 |
| 2023 | 131 | 278 |
| 2024 | 106 | 258 |
| 2025 | 148 | 203 |
| 2026 | 88 | 206 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Carotenoid preparations, preparation methods, and application thereof6 Oct 2026US 12,751,924 B2Innobio Corporation Limited
- Powder mixing device, and uses thereof6 Oct 2026US 12,751,925 B2University of Connecticut
- Formulation for oral administration, comprising triazine derivative6 Oct 2026US 12,751,955 B2Shionogi & Co., Ltd.
- Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone15 Sep 2026US 12,734,180 B2Janssen Pharmaceutica NV
- Liquisolid pharmaceutical formulation and process for manufacturing8 Sep 2026US 12,728,134 B2Rheinische Friedrich-Wilhelms-Universität Bonn
- Composition comprising particles containing reduced coenzyme q108 Oct 2026US 2026/0306424 A1Kaneka Corporation
- Moisture-proof acetyl l-carnitine8 Oct 2026US 2026/0306437 A1Nanjing Nutrabuilding Bio-Tech Co., Ltd.
- Oral pharmaceutical formulations containing 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives8 Oct 2026US 2026/0306514 A1Cadrenal Therapeutics, Inc.
- Composition containing cyclic peptide compound and surfactant1 Oct 2026US 2026/0294806 A1Chugai Seiyaku Kabushiki Kaisha
- Cannabidiol formulations1 Oct 2026US 2026/0294812 A1Dsm IP Assets B.V.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Particles incorporating surfactants for pulmonary drug delivery537US 5,855,913 AMassachusetts Instite of Technology · 1999
- Orally administrable opioid formulations having extended duration of effect437US 5,968,551 APurdue Pharma L. P. · 1999